Riskpilot← Back to searchSign inGet full accessBYG MED SJÆL ApS
APSActiveCVR 26997178Skyttebjerg 33Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2003— employees
Revenue 2025
DKK 584K
+27% vs 2024
EBITDA margin
171.9%
+118% vs 2024
Equity ratio
0.8%
Financial strength
Net profit 2025
DKK 481K
+1328% vs 2024
| Revenue | DKK 584K | +27% |
| EBITDA | DKK 1M | +118% |
| Net profit | DKK 481K | +1328% |
| Total assets | DKK 12,4M | +2% |
| Equity | DKK 99K | +126% |
| Employees | — | — |
Legal name
BYG MED SJÆL ApS
CVR number
26997178
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
22. december 2003
Share capital
DKK 125.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren
Company purpose
Selskabets formål er handel med-, udlejning og drift af- og ejerskab af fast ejendom samt dermed beslægtet virksomhed efter direktionens skøn.
Address
Skyttebjerg 33
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 644 | 566 | 442 | 460 | 584 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 644 | -134 | -8 | 460 | 1.004 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 644 | -134 | -8 | 460 | 1.004 |
| Net financials | 73 | 177 | -521 | -512 | -502 |
| Profit before tax | 716 | 44 | -530 | -52 | 502 |
| Tax | 158 | 164 | -17 | -13 | 21 |
| Net profit | 559 | -121 | -512 | -39 | 481 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 13.309 | 13.027 | 12.087 | 12.136 | 12.416 |
| Equity | 290 | 170 | -343 | -382 | 99 |
| Long-term debt | 4.071 | 5.322 | 5.072 | 4.881 | 4.681 |
| Short-term debt | 8.948 | 7.534 | 7.357 | 7.637 | 7.636 |
| Total debt | 13.019 | 12.857 | 12.429 | 12.518 | 12.317 |
EBITDA margin
171.9%
This company
15.8%
Market median
+988% vs market
20212025
Equity ratio
0.8%
This company
38.2%
Market median
-98% vs market
20212025
Return on equity
485.3%
This company
18.4%
Market median
+2538% vs market
20212025
Net profit margin
82.4%
This company
8.1%
Market median
+917% vs market
20212025
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20212025
Debt / equity
124.22×
This company
0.62×
Market median
-19935% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TL | Audit | 2003 |
TT Management | Management | 2025 |
| Former (1) | ||
MT Management | Management | 2003 – 2025 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25–33.32% | 0% | 2006 | |
| Company | 25–33.32% | 0% | 2006 | |
| Company | 25–33.32% | 0% | 2006 | |
| Company | 0% | 100% | 2006 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SJÆLEGLAD HOLDING ApS
BYG MED SJÆL ApS Board members of BYG MED SJÆL ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Torben Laurentz Wiberg | Audit | 0 companies |
| Mogens Tolstrup | Management | 0 companies |
| Tine Tolstrup | Management | 0 companies |